Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Friday broker round-up

Fri, 06th Jul 2012 09:35

Aviva: SocGen upgrades to hold from sell.Aberdeen: UBS cuts target from 310p to 300p, buy rating unchanged.Associated British Foods: Nomura raises target from 1,375p to 1,400p, buy recommendation unchanged.AstraZeneca: Jefferies downgrades from buy to hold, target left at 2,975p.AVEVA: Berenberg upgrades to buy, target lifted from 1,660p to 1,927p.Babcock: HB Markets downgrades to hold.Barclays: Bernstein downgrades to market perform, target cut from 360p to 180p.Big Yellow Group: Bank of America ML downgrades to neutral, target lifted from 285p to 315p.Carillion: UBS downgrades to sell, target cut from 285p to 230p; Liberum Capital downgrades to sell, target cut from 270p to 235p, sell rating kept.Dunlem: UBS cuts target from 585p to 560p, buy rating kept.Intertek: Morgan Stanley downgrades to underweight, target raised from 2,510p to 2,740p.Ladbrokes: Davy Research downgrades to neutral.Lonmin: CIBC downgrades to sector performer, target cut from 1,250p to 735p.Marshalls: Northland Capital downgrades to hold, target cut from 110p to 85p.Sage: Berenberg upgrades to buy.Sainsbury: AlphaValue downgrades to reduce.Travis Perkins: Morgan Stanley downgrades to underweight, target cut from 1,260p to 1,050p.Wolseley: Morgan Stanley downgrades to equal weight, target cut from 2,700p to 2,540p.BC

Related Shares

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.